These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29672108)

  • 21. Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia.
    Hauser MJ; Isbrandt D; Roeper J
    Behav Brain Res; 2017 Aug; 332():316-326. PubMed ID: 28634108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
    Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
    Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.
    Gaisler-Salomon I; Miller GM; Chuhma N; Lee S; Zhang H; Ghoddoussi F; Lewandowski N; Fairhurst S; Wang Y; Conjard-Duplany A; Masson J; Balsam P; Hen R; Arancio O; Galloway MP; Moore HM; Small SA; Rayport S
    Neuropsychopharmacology; 2009 Sep; 34(10):2305-22. PubMed ID: 19516252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
    Li M; He W; Mead A
    Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
    Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
    Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation.
    Richtand NM; Ahlbrand R; Horn P; Stanford K; Bronson SL; McNamara RK
    J Psychiatr Res; 2011 Sep; 45(9):1194-201. PubMed ID: 21440257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis.
    Omeiza NA; Bakre AG; Abdulrahim HA; Isibor H; Ezurike PU; Sowunmi AA; Ben-Azu B; Aderibigbe AO
    J Ethnopharmacol; 2022 Sep; 295():115432. PubMed ID: 35659625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Schizophrenia and amphetamine dependence. A case report].
    Dervaux A; Krebs MO; Laqueille X
    Encephale; 2005; 31(2):247-50. PubMed ID: 15959451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A rare and not very studied disorder: childhood-onset schizophrenia. A case report].
    Bailly D; de Chouly de Lenclave MB
    Encephale; 2004; 30(6):540-7. PubMed ID: 15738856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia.
    Azimi Sanavi M; Ghazvini H; Zargari M; Ghalehnoei H; Hosseini-Khah Z
    Neurosci Lett; 2022 Jan; 770():136354. PubMed ID: 34801642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First person account: living with the delusions and effects of schizophrenia.
    Weiner SK
    Schizophr Bull; 2003; 29(4):877-9. PubMed ID: 14989422
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
    Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
    Calzavara MB; Medrano WA; Levin R; Kameda SR; Andersen ML; Tufik S; Silva RH; Frussa-Filho R; Abílio VC
    Schizophr Bull; 2009 Jul; 35(4):748-59. PubMed ID: 18281713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
    Ong JC; Brody SA; Large CH; Geyer MA
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1163-71. PubMed ID: 16123308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
    Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of untreated psychosis and time to treatment response for delusions and hallucinations.
    Gunduz-Bruce H; McMeniman M; Robinson DG; Woerner MG; Kane JM; Schooler NR; Lieberman JA
    Am J Psychiatry; 2005 Oct; 162(10):1966-9. PubMed ID: 16199847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
    Talpos J; Aerts N; Waddell J; Steckler T
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
    Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice.
    Brody SA; Geyer MA; Large CH
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):240-6. PubMed ID: 12698229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.
    Canever L; Oliveira L; D'Altoé de Luca R; Correa PT; de B Fraga D; Matos MP; Scaini G; Quevedo J; Streck EL; Zugno AI
    Oxid Med Cell Longev; 2010; 3(6):421-7. PubMed ID: 21270541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.